Wine as a biological fluid: history, production, and role in disease prevention - PubMed (original) (raw)
Review
Wine as a biological fluid: history, production, and role in disease prevention
G J Soleas et al. J Clin Lab Anal. 1997.
Abstract
Wine has been part of human culture for 6,000 years, serving dietary and socio-religious functions. Its production takes place on every continent, and its chemical composition is profoundly influenced by enological techniques, the grape cultivar from which it originates, and climatic factors. In addition to ethanol, which in moderate consumption can reduce mortality from coronary heart disease by increasing high-density lipoprotein cholesterol and inhibiting platelet aggregation, wine (especially red wine) contains a range of polyphenols that have desirable biological properties. These include the phenolic acids (p-coumaric, cinnamic, caffeic, gentisic, ferulic, and vanillic acids), trihydroxy stilbenes (resveratrol and polydatin), and flavonoids (catechin, epicatechin, and quercetin). They are synthesized by a common pathway from phenylalanine involving polyketide condensation reactions. Metabolic regulation is provided by competition between resveratrol synthase and chalcone synthase for a common precursor pool of acyl-CoA derivatives. Polymeric aggregation gives rise, in turn to the viniferins (potent antifungal agents) and procyanidins (strong antioxidants that also inhibit platelet aggregation). The antioxidant effects of red wine and of its major polyphenols have been demonstrated in many experimental systems spanning the range from in vitro studies (human low-density lipoprotein, liposomes, macrophages, cultured cells) to investigations in healthy human subjects. Several of these compounds (notably catechin, quercetin, and resveratrol) promote nitric oxide production by vascular endothelium; inhibit the synthesis of thromboxane in platelets and leukotriene in neutrophils, modulate the synthesis and secretion of lipoproteins in whole animals and human cell lines, and arrest tumour growth as well as inhibit carcinogenesis in different experimental models. Target mechanisms to account for these effects include inhibition of phospholipase A2 and cyclo-oxygenase, inhibition of phosphodiesterase with increase in cyclic nucleotide concentrations, and inhibition of several protein kinases involved in cell signalling. Although their bioavailability remains to be fully established, red wine provides a more favourable milieu than fruits and vegetables, their other dietary source in humans.
Similar articles
- Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway.
Chan MM, Mattiacci JA, Hwang HS, Shah A, Fong D. Chan MM, et al. Biochem Pharmacol. 2000 Nov 15;60(10):1539-48. doi: 10.1016/s0006-2952(00)00471-8. Biochem Pharmacol. 2000. PMID: 11020457 - Cardioprotection of red wine: role of polyphenolic antioxidants.
Das DK, Sato M, Ray PS, Maulik G, Engelman RM, Bertelli AA, Bertelli A. Das DK, et al. Drugs Exp Clin Res. 1999;25(2-3):115-20. Drugs Exp Clin Res. 1999. PMID: 10370873 Review. - Potent inhibitory action of red wine polyphenols on human breast cancer cells.
Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Martin PM, Castanas E. Damianaki A, et al. J Cell Biochem. 2000 Jun 6;78(3):429-41. doi: 10.1002/1097-4644(20000901)78:3<429::aid-jcb8>3.0.co;2-m. J Cell Biochem. 2000. PMID: 10861841 - Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines.
Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C, Kouroumalis E, Martin PM, Castanas E. Kampa M, et al. Nutr Cancer. 2000;37(2):223-33. doi: 10.1207/S15327914NC372_16. Nutr Cancer. 2000. PMID: 11142097 - Inhibition by wine polyphenols of peroxynitrite-initiated chemiluminescence and NADH oxidation.
Boveris A, Valdez L, Alvarez S. Boveris A, et al. Ann N Y Acad Sci. 2002 May;957:90-102. doi: 10.1111/j.1749-6632.2002.tb02908.x. Ann N Y Acad Sci. 2002. PMID: 12074964 Review.
Cited by
- Resveratrol-induced gene expression profiles in human prostate cancer cells.
Jones SB, DePrimo SE, Whitfield ML, Brooks JD. Jones SB, et al. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):596-604. doi: 10.1158/1055-9965.EPI-04-0398. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767336 Free PMC article. - Modulatory effects of Pluchea lanceolata against chemically induced oxidative damage, hyperproliferation and two-stage renal carcinogenesis in Wistar rats.
Jahangir T, Sultana S. Jahangir T, et al. Mol Cell Biochem. 2006 Oct;291(1-2):175-85. doi: 10.1007/s11010-006-9213-8. Epub 2006 Jun 10. Mol Cell Biochem. 2006. PMID: 16767495 - Effects of resveratrol in inflammatory arthritis.
Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B. Elmali N, et al. Inflammation. 2007 Apr;30(1-2):1-6. doi: 10.1007/s10753-006-9012-0. Inflammation. 2007. PMID: 17115116 - Resveratrol ameliorates oxidative DNA damage and protects against acrylamide-induced oxidative stress in rats.
Alturfan AA, Tozan-Beceren A, Sehirli AO, Demiralp E, Sener G, Omurtag GZ. Alturfan AA, et al. Mol Biol Rep. 2012 Apr;39(4):4589-96. doi: 10.1007/s11033-011-1249-5. Epub 2011 Sep 24. Mol Biol Rep. 2012. PMID: 21947844 - Phytoestrogens for the Management of Endometriosis: Findings and Issues.
Cai X, Liu M, Zhang B, Zhao SJ, Jiang SW. Cai X, et al. Pharmaceuticals (Basel). 2021 Jun 14;14(6):569. doi: 10.3390/ph14060569. Pharmaceuticals (Basel). 2021. PMID: 34198709 Free PMC article. Review.
References
- Goldberg DM, Hahn SE, Parks JG: Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 237: 155–187, 1995. - PubMed
- Kannel WB, Ellison RC: Alcohol and coronary heart disease: The evidence for a protective effect. Clin Chim Acta 246: 59–76, 1996. - PubMed
- Criqui MH: Alcohol and coronary heart disease: Consistent relationship and public health implications. Clin Chim Acta 246: 51–57, 1996. - PubMed
- Steinmetz KA, Potter JD: Vegetables, fruit and cancer: I. Epidemiology. Cancer Causes Control 2: 325–357, 1991. - PubMed
- Hertog MGL, Feakone EJM, Holleman PCH, Katan JB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342: 1007–1011, 1993. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources